NIVABUPA - IntraDay Trade Analysis with Live Signals
Back to ListIntraDay Trade Rating: 2.6
| Stock Code | NIVABUPA | Market Cap | 14,559 Cr. | Current Price | 78.7 ₹ | High / Low | 95.2 ₹ |
| Book Value | 0.00 ₹ | Dividend Yield | 0.00 % | ROCE | 7.45 % | ROE | 8.18 % |
| Face Value | 10.0 ₹ | DMA 50 | 77.0 ₹ | DMA 200 | 78.5 ₹ | Chg in FII Hold | -0.41 % |
| Chg in DII Hold | 0.73 % | PAT Qtr | -87.6 Cr. | PAT Prev Qtr | -35.3 Cr. | RSI | 56.8 |
| MACD | 0.62 | Volume | 22,05,337 | Avg Vol 1Wk | 19,50,643 | Low price | 61.0 ₹ |
| High price | 95.2 ₹ | 52w Index | 51.8 % | Qtr Profit Var | -762 % | EPS | -0.03 ₹ |
| Industry PE | 33.8 |
📊 Analysis: NIVABUPA shows weak intraday potential. Current price (78.7 ₹) is hovering around the 200 DMA (78.5 ₹) and slightly above the 50 DMA (77.0 ₹), indicating neutral short-term support. RSI at 56.8 is mildly positive, while MACD (0.62) suggests weak bullish momentum. Volume (22.0L) is above average (19.5L), showing active participation, but fundamentals remain negative with losses and weak efficiency.
💰 Optimal Buy Price: 77.5 ₹ – 79.0 ₹ (speculative entry near support)
📈 Profit-Taking Levels: 82.0 ₹ – 85.0 ₹
📉 Stop-Loss / Loss Protection: 75.5 ₹
⏱️ If Already Holding: Exit intraday if price fails to hold above 77.5 ₹ or if RSI dips below 54. Book profits quickly if price approaches 82–85 ₹ with weakening momentum or reversal signals.
Positive
- Trading near DMA 50 and DMA 200 provides technical support.
- DII holdings increased (+0.73%), showing domestic institutional support.
- Volume above average indicates active trader interest.
Limitation
- No dividend yield, reducing investor appeal.
- Book value unavailable, limiting margin of safety analysis.
- ROCE (7.45%) and ROE (8.18%) are modest compared to peers.
- EPS (-0.03 ₹) reflects losses.
Company Negative News
- Quarterly PAT turned negative (-87.6 Cr. vs -35.3 Cr.), showing worsening losses.
- Quarterly profit variation (-762%) highlights severe margin pressure.
- FII holdings decreased (-0.41%), showing reduced foreign investor confidence.
Company Positive News
- DII inflows (+0.73%) support fundamentals despite weak earnings.
- RSI above 55 suggests mild momentum support for speculative trades.
Industry
- Industry P/E at 33.8 highlights sector profitability, but NIVABUPA lacks earnings to compare.
- Insurance and healthcare sector remains resilient long-term, though valuations depend on profitability and growth visibility.
Conclusion
⚖️ NIVABUPA is a weak candidate for intraday trading today. Fundamentals show losses and poor efficiency, though technical support near DMA levels and higher volume may attract speculative interest. Best suited only for short-term scalps with tight stop-loss discipline and quick profit booking around 82–85 ₹.
Would you like me to also prepare a workflow-ready HTML template with peer benchmarking overlays (e.g., comparing NIVABUPA with ICICI Lombard, HDFC Life, and SBI Life) so you can integrate sector-relative strength into your intraday reports?